ATE370413T1 - Nanopartikel für bioaffinitätstests - Google Patents

Nanopartikel für bioaffinitätstests

Info

Publication number
ATE370413T1
ATE370413T1 AT04725404T AT04725404T ATE370413T1 AT E370413 T1 ATE370413 T1 AT E370413T1 AT 04725404 T AT04725404 T AT 04725404T AT 04725404 T AT04725404 T AT 04725404T AT E370413 T1 ATE370413 T1 AT E370413T1
Authority
AT
Austria
Prior art keywords
nanoparticle
particle
several
binding
shell
Prior art date
Application number
AT04725404T
Other languages
English (en)
Inventor
Tero Soukka
Teemu Korpimaeki
Urpo Lamminmaeki
Marko Virta
Original Assignee
Turun Yliopisto
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FI20030615A external-priority patent/FI20030615A0/fi
Application filed by Turun Yliopisto filed Critical Turun Yliopisto
Application granted granted Critical
Publication of ATE370413T1 publication Critical patent/ATE370413T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54346—Nanoparticles
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
    • G01N33/587—Nanoparticles
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Nanotechnology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Peptides Or Proteins (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
AT04725404T 2003-04-02 2004-04-02 Nanopartikel für bioaffinitätstests ATE370413T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45937403P 2003-04-02 2003-04-02
FI20030615A FI20030615A0 (fi) 2003-04-24 2003-04-24 Nanopartikkeli bioaffiniteettimäärityksiin

Publications (1)

Publication Number Publication Date
ATE370413T1 true ATE370413T1 (de) 2007-09-15

Family

ID=33133059

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04725404T ATE370413T1 (de) 2003-04-02 2004-04-02 Nanopartikel für bioaffinitätstests

Country Status (6)

Country Link
US (1) US20110300558A1 (de)
EP (1) EP1608977B1 (de)
AT (1) ATE370413T1 (de)
DE (1) DE602004008242T2 (de)
ES (1) ES2293243T3 (de)
WO (1) WO2004088313A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070048383A1 (en) * 2005-08-25 2007-03-01 Helmus Michael N Self-assembled endovascular structures
GB0621894D0 (en) * 2006-11-02 2006-12-13 Iti Scotland Ltd Magnetic recognition system
WO2008067591A1 (en) * 2006-12-04 2008-06-12 Innovative Purification Technologies Pty Ltd Protein particles
WO2008144817A1 (en) * 2007-05-30 2008-12-04 Innovative Purification Technologies Pty Ltd Fluorescent protein particles
EP2660601B1 (de) * 2007-08-17 2015-10-07 Korea Advanced Institute of Science and Technology Verfahren für den Nachweis molekularer Wechselwirkungen
CN102608327A (zh) * 2012-03-01 2012-07-25 江苏省原子医学研究所 一种铁蛋白的示踪标记方法
KR101492167B1 (ko) * 2013-04-08 2015-02-10 한국과학기술연구원 페리틴 단백질을 함유하는 표적-특이적 프로브 및 이를 이용한 바이오마커의 탐지

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1308022C (en) * 1988-08-11 1992-09-29 Eleftherios P. Diamandis Multiple fluorescence labelling with europium chelators
EP0487615B1 (de) * 1989-08-18 1994-01-05 Monsanto Company Ferritinanaloge
EP1262489A1 (de) * 2001-05-14 2002-12-04 Matsushita Electric Industrial Co., Ltd. Komplex aus rekombinantem Ferritin und einem Edelmetall sowie dieses Ferritin kodierende DNA
CN1659187A (zh) * 2002-05-10 2005-08-24 新世纪药品有限公司 融合铁蛋白在疫苗和其他方面的应用

Also Published As

Publication number Publication date
WO2004088313A1 (en) 2004-10-14
US20110300558A1 (en) 2011-12-08
ES2293243T3 (es) 2008-03-16
DE602004008242T2 (de) 2008-05-15
EP1608977A1 (de) 2005-12-28
DE602004008242D1 (de) 2007-09-27
EP1608977B1 (de) 2007-08-15

Similar Documents

Publication Publication Date Title
WO2005095461A3 (en) Gold-binding protein and use thereof
WO2006034278A3 (en) Methods and compositions for detecting cancer using components of the u2 spliceosomal particle
HUP0303749A2 (hu) Veserák-specifikus tumormarkerek
ATE541590T1 (de) Modifizierte antikörper-fragmente
DE60310032D1 (de) Kern-Mantel Nanoteilchen für (F) RET-Testverfahren
WO2007061793A3 (en) Modified cardiolipin and uses therefor
IL188094A0 (en) Il-1?? binding antibodies and fragments thereof
WO2006119203A3 (en) Fluorescence lateral flow immunoassay
EP2154245A3 (de) Zusammensetzung und Verfahren zur Diagnose von Nierenkrebs und zur Vorhersage einer Prognose für einen Nierenkrebspatienten
ATE364178T1 (de) Bestimmung von analytcharakteristika auf der grundlage von bindungseigenschaften
DE602004019812D1 (de) Marker für neuromyelitis optica
MA30922B1 (fr) Anticorps d'agonistes de trkb et leurs utilisations
ATE331960T1 (de) Diagnose von myokardinfarkt und akutem koronarsyndrom durch kombination von markern
CA2798562A1 (en) Methods and compositions for the diagnosis and treatment of thyroid cancer
WO2006116631A3 (en) Cancer specific pcna isoform binding antibodies and uses thereof
ATE370413T1 (de) Nanopartikel für bioaffinitätstests
DE602006018424D1 (de) Peptide zum nachweis von ehrlichia ewingii antikörper
WO2008029031A8 (fr) Test pharmaco diagnostique ciblant l' oncologie
ES2527830T3 (es) Método para detectar el cáncer de páncreas mediante el marcador serológico ULBP2
WO2002027031A3 (en) Methods and reagents for live-cell gene expression quantification
WO2007076013A3 (en) Homocysteine immunoassay
WO2006099537A3 (en) The use of antibody-surrogate antigen systems for detection of analytes
DE60315343D1 (de) Neuartige verwendungen von durch ble-gene kodierten proteinen und antibiotika aus der bleomycin-familie
WO2006119264A3 (en) Antibodies against histone modifications for clinical diagnosis and prognosis of cancer
WO2006073563A3 (en) Fluorescent affinity tag to enhance phosphoprotein detection

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties